Huw W. Thomas
St Marks Hospital
Middlesex, ENG, United Kingdom
Middlesex, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Aspirin for cancer prevention in individuals with Lynch syndrome: first results from the CaPP3 multicentre, randomised, double-blind, non-inferiority trial.
Journal: The lancet. Gastroenterology & hepatology
Published: December 16, 2025
Cancer Prevention with Resistant Starch in Lynch Syndrome Patients in the CAPP2-Randomized Placebo Controlled Trial: Planned 10-Year Follow-up.
Journal: Cancer prevention research (Philadelphia, Pa.)
Published: February 04, 2022
Telehealth in cancer care: during and beyond the COVID-19 pandemic.
Journal: Internal medicine journal
Published: July 19, 2020
Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double-blind, randomised, placebo-controlled trial.
Journal: Lancet (London, England)
Published: November 20, 2019
Obesity, Aspirin, and Risk of Colorectal Cancer in Carriers of Hereditary Colorectal Cancer: A Prospective Investigation in the CAPP2 Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 19, 2015
Long-term effect of resistant starch on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial.
Journal: The Lancet. Oncology
Published: November 13, 2012
Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial.
Journal: Lancet (London, England)
Published: November 01, 2011
Showing 1-11 of 11
Last Updated: 09/26/2026